Biopharma

Walgreens: Bridging the gap between patient and medication

Ramita Tandon, Chief Biopharma Services Officer at Walgreens on the company’s ef...

Tariffs raise concern among generic drugmakers, as advo...

“There is not a single member of AAM who has not raised concerns about the tarif...

Eli Lilly inks duo of deals, teaming with AdvanCell, Ol...

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and Ol...

The biggest biotech news stories from the weekend

Want to stay on top of the science and politics driving biotech today? Sign up t...

Regulatory tracker: Bristol Myers snags dual cancer end...

In this tracker, Fierce Pharma is recording the regulatory progress of in-market...

Bristol Myers angles Breyanzi for another blood cancer ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-dir...

STAT+: Pharmalittle: We’re reading about Trump orders a...

Public health experts worry the FDA workforce will be slashed, impeding the abil...

STAT+: Lilly expands GLP-1 research to hypertension, ne...

Morning. Today, we have a look at the White House's reported plans to make major...

More evidence on bird flu transmissibility 

Get your daily dose of health and medicine every weekday with STAT’s free newsle...

With Teva competition heating up, Neurocrine's tame Ing...

Neurocrine's stock price took a tumble Friday after the company revealed its 202...

Product-specific bioequivalence guidance

Product-specific bioequivalence guidance

Methylphenidate, prolonged-release tablet 18 mg, 27 mg,...

Methylphenidate, prolonged-release tablet 18 mg, 27 mg, 36 mg and 54 mg and modi...

Kineta sells Genentech and Merck deals to investor ahea...

Kineta has found a new home for deals with Genentech and Merck & Co. Tidying up ...

AbbVie scores FDA nod for Pfizer-partnered antibiotic E...

Ten months after Pfizer scored approval in Europe for Emblaveo to treat complica...

An additional treatment option with TAGRISSO® (osimerti...

Learn about a treatment option with TAGRISSO® (osimertinib).

Executive Interviews at JPM Week 2025

Fierce Pharma sits down with healthcare executives at Fierce JPM Week 2025. Indu...

The Patient as Your Guide: Thriving in New Commercial M...

Patient relationships are the linchpin of commercial success. Learn how AI, data...

After phase 3 miss, Relmada picks up midstage Tourette'...

After sharing plans to shutter last summer, Asarina Pharma has managed to sell o...

List of signals discussed at PRAC since September 2012

List of signals discussed at PRAC since September 2012

Members of the Coordinating group of European network o...

Members of the Coordinating group of European network of paediatric research at ...

Meeting of the Medicine Shortages Single Point of Conta...

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, ...

Pharmacovigilance Risk Assessment Committee (PRAC): 25 ...

Pharmacovigilance Risk Assessment Committee (PRAC): 25 - 28 November 2024, Europ...

Minutes of the PRAC meeting 25-28 November 2024

Minutes of the PRAC meeting 25-28 November 2024

ACT EU multi-stakeholder platform annual meeting, Onlin...

ACT EU multi-stakeholder platform annual meeting, Online, European Medicines Age...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.